What is a biosimilar product ? A biosimilar is a biological medicine (i.e., a medicine whose active substance is made by a living organism) highly similar to another already approved biological medicine (the « reference medicine »EMA, [1]) . According to the European Medicines Agency (« EMA »), biosimilar medicines have become major therapeutic...
ReadArchives
- 2024-02-29
- Gaëlle MERLIER, Bastien PAVEC
- Life sciences
- 2023-04-12
- Mathieu LE TACON, Jeanne BOSSI MALAFOSSE, Gaëlle MERLIER
- Mergers & Acquisitions - Corporate law, Civil and commercial litigation, Employment law - Social welfare law, Wealth law & taxation, Corporate taxation, Real estate, Life sciences, Personal data
DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2023 categories : Construction – Tier 3 Data privacy and data protection – Tier 3 Dispute resolution : White-collar crime – Tier 4 Employment – Tier 4 Industry focus : Healthcare and life sciences – Tier 3 Mergers & Acquisitions – Tier 5 Private equity : venture/growth...
Read- 2022-06-16
- Jeanne BOSSI MALAFOSSE
- Personal data, Life sciences
Launched in June 2021 by three founding members (AstraZeneca, Docaposte and Impact Healthcare), the AgorIA Santé consortium aims at bringing together research stakeholders to facilitate the analysis of real-life health data for public health purposes. AgorIA Santé thus offers a secure technological platform for hosting and analysing health data...
Read- 2022-04-12
- Mathieu LE TACON, Jeanne BOSSI MALAFOSSE
- Civil and commercial litigation, Mergers & Acquisitions - Corporate law, Employment law - Social welfare law, Wealth law & taxation, Corporate taxation, Real estate, Life sciences, Personal data
DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2022 categories : Construction – Tier 3 Data privacy and data protection – Tier 3 Dispute resolution : White-collar crime – Tier 4 Employment – Tier 4 Industry focus : Healthcare and life sciences – Tier 4 Mergers and acquisitions – Tier 5 Private equity : venture/growth...
Read- 2022-01-14
- Gaëlle MERLIER
- Life sciences
Gaëlle Merlier is joining the DELSOL Avocats Life Sciences practice as a partner accompanied by associate Bastien Pavec, who worked alongside her at Clifford Chance. The Life Sciences team, led by another specialist in the sector, Jeanne Bossi Malafosse, now has two partners and four associates. They assist their clients, health and medical...
Read- 2021-06-24
- Jeanne BOSSI MALAFOSSE
- Life sciences, Personal data
AstraZeneca, Docaposte and Impact Healthcare have created the « Agoria Santé » consortium to provide public and private players with a controlled legal framework and shared governance to carry out research projects on health data. The consortium offers a secure platform for hosting and analyzing health data. The consortium’s health data warehouse...
Read- 2021-04-15
- Jeanne BOSSI MALAFOSSE
- Personal data, Life sciences, Real estate, Mergers & Acquisitions - Corporate law
DELSOL Avocats is proud to be ranked in 6 Legal 500 EMEA 2021 categories : The Regions - Tier 1 « Delsol Avocats has its original office in Lyon and another strong base in Paris, each gathering about half of the firm’s. It ranks among France’s best independent mid-size market firms, with strong expertise in the full range of business law areas....
Read- 2020-07-16
- Jeanne BOSSI MALAFOSSE
- Mergers & Acquisitions - Corporate law, Employment law - Social welfare law, Life sciences, Personal data, Tax law, Real estate
DELSOL Avocats is proud to be ranked in 8 categories by the Legal 500 Paris 2020 : The Régions - Tier 1 - « Founded in Lyon, Delsol Avocats is nationally renowned. The firm brings together a total of approximately 120 lawyers divided between its Lyon and Paris offices. The Paris office has experienced strong growth in recent years and is now...
Read- 2020-04-16
- Civil and commercial litigation, Mergers & Acquisitions - Corporate law, Non-profit organisations - Social and solidarity-based entrepreneurship, Employment law - Social welfare law, Tax law, Real estate, Public law, Life sciences, Personal data
Considering the latest developments relating to Covid-19 and government announcements, we would like to inform you with full transparency of the measures we anticipated and implemented within our firm. We have all the IT and technical capacities enabling us to manage files remotely. Dematerialization of both internal process and legal...
Read- 2020-04-16
- Jeanne BOSSI MALAFOSSE
- Mergers & Acquisitions - Corporate law, Employment law - Social welfare law, Tax law, Real estate, Personal data, Life sciences
DELSOL Avocats is proud to be ranked in 8 Legal 500 EMEA 2020 categories : The Regions - Tier 1 « Founded in Lyon, Delsol Avocats has built itself a great reputation at national level. The firm fields a total of some 120 lawyers who are based in Lyon and Paris. The Paris office has grown significantly these past few years and now houses most...
ReadTraining has been part of the DNA of DELSOL Avocats since the outset, and the firm is now launching a training arm, DELSOL Avocats Formations, to extend its services beyond legal advice and assistance. Whether it be the university lecturing undertaken by members of staff or the conferences, webinars and workshops they run, the process of...
Read- 2019-04-15
- Mergers & Acquisitions - Corporate law, Employment law - Social welfare law, Tax law, Real estate, Life sciences
DELSOL Avocats is proud to rank in 6 categories of the Legal 500 EMEA 2019 : The Regions - Tier 1 « Originally founded in Lyon, Delsol Avocats is one of France’s most well known regional firms, with a reputation that is well established at national level. Its resources are now almost equally split between its Paris and Lyon offices. The firm...
Read- 2017-03-17
- Life sciences
In the March 2017 issue of La Tribune de l’Assurance Thomas ROCHE explains the various controversies that will result from the Jardé law Thomas ROCHE, a partner in the "Life Sciences" department, outlines the three major changes brought about by the application of the Jardé law, particularly in relation to risk-inherent interventional research...
Read- 2016-05-03
- Life sciences
Thomas ROCHE wrote an article for the April 2016 Expertises des Systèmes d’Information analysing an important change in the law relating to data protection Thomas ROCHE, a partner in the "Life Sciences" department, takes a stand in an article published in the April 2016 issue of Expertises des Systèmes d’Information about the recent merger of...
Read